MedicinePenn Medicine breakthrough in CRISPR-based neuro-regeneration
The Perelman School of Medicine announces human trials for a novel gene-editing vector targeting ALS.
Sarah Chen · 6m
Medicine, biotechnology, and clinical research across the league.
MedicineThe Perelman School of Medicine announces human trials for a novel gene-editing vector targeting ALS.
Life SciencesA BrainGate consortium trial reports the first sustained two-year recovery in a tetraplegic patient.